Loading...
Helius Medical Technologies, Inc.
HSM.TO•TSX
Healthcare
Medical - Devices
CA$18.35
CA$-0.32(-1.71%)
Helius Medical Technologies, Inc. (HSM.TO) Company Profile & Overview
Explore Helius Medical Technologies, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Helius Medical Technologies, Inc. (HSM.TO) Company Profile & Overview
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator (PoNS), a medical device in Canada for the treatment of chronic balance deficit due to mild-to-moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function. The company is headquartered in Newtown, Pennsylvania.
SectorHealthcare
IndustryMedical - Devices
CEODane Carl Andreeff
Contact Information
Company Facts
19 Employees
IPO DateApr 18, 2016
CountryUS